16 results
diabetes endocrinology summary inhibitors management medications sideeffects agonists antipsychotics comparison diagnosis dosing dpp4 mechanisms oral psychiatry sglt2 a1c allopurinol classification
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... the pancreas (GLP ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
GLP-1 Agonists ... However, GLP-1's ... Common side effects ... #Pharmacology #Dosing ... #Diabetes #DM2
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. #pharmacology
mechanism of action, side ... #pharmacology #dm2
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... disease Common Side ... Toxicities: • GI side ... #Metformin #Pharmacology ... #Summary #DM2 #
Diabetes Medication Choice -Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
metformin, SGLT-i, GLP1 ... Diabetes #Type2 #DM2 ... Reduction #Costs #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... normally inactivates GLP ... combination therapy with GLP-I ... failure Common Side ... #Summary #DM2 #
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... in CKD Common Side ... Sulfonylureas #Pharmacology ... #Summary #DM2 #
Oral Hypoglycemics in Diabetes Management 1 INSULIN SENSITIZER • TZD -
INCRETIN AGENTS • GLP ... - Prevents GLP ... Diabetes #Management #pharmacology ... #DM2 #DMII #Classification
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... mL/minute/1.73 m2 ... of use) Common Side ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... (& only) oral GLP1 ... GI upset as a side ... minimize this side ... semaglutide #Diabetes #Pharmacology
No results found for "Wide pocus pharmacology pulmonaryembolism dm2 glp1"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Wide #pocus #pharmacology #pulmonaryembolism #dm2 #glp1